Howard Hughes (HHH) Competitors $83.82 -1.27 (-1.50%) As of 03:03 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HHH vs. TSHA, ZG, WPC, HLI, JEF, GLPI, DOC, REG, AMH, and HSTShould you be buying Howard Hughes stock or one of its competitors? The main competitors of Howard Hughes include Taysha Gene Therapies (TSHA), Zillow Group (ZG), W.P. Carey (WPC), Houlihan Lokey (HLI), Jefferies Financial Group (JEF), Gaming and Leisure Properties (GLPI), Healthpeak Properties (DOC), Regency Centers (REG), American Homes 4 Rent (AMH), and Host Hotels & Resorts (HST). Howard Hughes vs. Its Competitors Taysha Gene Therapies Zillow Group W.P. Carey Houlihan Lokey Jefferies Financial Group Gaming and Leisure Properties Healthpeak Properties Regency Centers American Homes 4 Rent Host Hotels & Resorts Taysha Gene Therapies (NASDAQ:TSHA) and Howard Hughes (NYSE:HHH) are related companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, media sentiment, dividends, profitability, institutional ownership and valuation. Is TSHA or HHH more profitable? Howard Hughes has a net margin of 12.85% compared to Taysha Gene Therapies' net margin of -1,144.97%. Howard Hughes' return on equity of 10.51% beat Taysha Gene Therapies' return on equity.Company Net Margins Return on Equity Return on Assets Taysha Gene Therapies-1,144.97% -78.44% -44.82% Howard Hughes 12.85%10.51%3.15% Do institutionals & insiders have more ownership in TSHA or HHH? 77.7% of Taysha Gene Therapies shares are held by institutional investors. Comparatively, 93.8% of Howard Hughes shares are held by institutional investors. 3.8% of Taysha Gene Therapies shares are held by company insiders. Comparatively, 48.0% of Howard Hughes shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more risk & volatility, TSHA or HHH? Taysha Gene Therapies has a beta of 0.99, meaning that its share price is 1% less volatile than the S&P 500. Comparatively, Howard Hughes has a beta of 1.23, meaning that its share price is 23% more volatile than the S&P 500. Does the media favor TSHA or HHH? In the previous week, Taysha Gene Therapies had 20 more articles in the media than Howard Hughes. MarketBeat recorded 28 mentions for Taysha Gene Therapies and 8 mentions for Howard Hughes. Howard Hughes' average media sentiment score of 0.87 beat Taysha Gene Therapies' score of 0.36 indicating that Howard Hughes is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Taysha Gene Therapies 3 Very Positive mention(s) 5 Positive mention(s) 17 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Howard Hughes 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer TSHA or HHH? Taysha Gene Therapies currently has a consensus price target of $9.00, indicating a potential upside of 99.34%. Howard Hughes has a consensus price target of $83.33, indicating a potential downside of 0.58%. Given Taysha Gene Therapies' higher probable upside, equities analysts plainly believe Taysha Gene Therapies is more favorable than Howard Hughes.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Taysha Gene Therapies 1 Sell rating(s) 0 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.80Howard Hughes 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.80 Which has better valuation and earnings, TSHA or HHH? Howard Hughes has higher revenue and earnings than Taysha Gene Therapies. Taysha Gene Therapies is trading at a lower price-to-earnings ratio than Howard Hughes, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTaysha Gene Therapies$8.10M152.10-$89.30M-$0.34-13.28Howard Hughes$1.75B2.84$200.55M$4.5718.34 SummaryHoward Hughes beats Taysha Gene Therapies on 12 of the 16 factors compared between the two stocks. Get Howard Hughes News Delivered to You Automatically Sign up to receive the latest news and ratings for HHH and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HHH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HHH vs. The Competition Export to ExcelMetricHoward HughesREAL ESTATE DEV IndustryFinance SectorNYSE ExchangeMarket Cap$4.97B$2.87B$12.73B$21.95BDividend YieldN/A2.53%5.51%3.56%P/E Ratio18.3010.4830.2129.66Price / Sales2.844.1330.4699.82Price / Cash8.7528.5619.7218.33Price / Book1.481.052.304.61Net Income$200.55M-$90.00M$1.02B$1.01B7 Day Performance2.02%-0.09%0.18%0.16%1 Month Performance6.26%1.22%0.58%2.32%1 Year Performance11.19%-1.84%541.23%13.95% Howard Hughes Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HHHHoward Hughes2.2659 of 5 stars$83.82-1.5%$83.33-0.6%+11.2%$4.97B$1.75B18.30608TSHATaysha Gene Therapies2.535 of 5 stars$3.16-2.8%$8.29+162.2%+119.9%$886.58M$8.33M-9.29180ZGZillow Group4.5466 of 5 stars$77.95+1.0%$86.18+10.6%+17.3%$18.69B$2.24B-299.816,856Analyst ForecastWPCW.P. Carey3.3935 of 5 stars$68.04-0.6%$67.22-1.2%+13.0%$14.99B$1.64B44.76190Positive NewsHLIHoulihan Lokey4.8565 of 5 stars$206.03+0.0%$210.60+2.2%+22.0%$14.48B$2.39B34.681,100JEFJefferies Financial Group4.8558 of 5 stars$66.67-0.1%$71.67+7.5%-3.4%$13.76B$7.03B25.167,822Trending NewsGLPIGaming and Leisure Properties4.5731 of 5 stars$46.870.0%$52.85+12.8%-9.4%$13.27B$1.57B18.1720Positive NewsDOCHealthpeak Properties4.8673 of 5 stars$19.00+0.3%$21.45+12.9%-13.0%$13.16B$543.46M79.17200Trending NewsDividend AnnouncementREGRegency Centers4.3281 of 5 stars$72.22+1.0%$78.73+9.0%+0.4%$12.98B$1.45B33.75440News CoverageAnalyst UpgradeAMHAmerican Homes 4 Rent4.9022 of 5 stars$32.45-0.5%$39.83+22.8%-15.3%$12.10B$1.73B29.231,730Positive NewsHSTHost Hotels & Resorts4.2613 of 5 stars$17.43-0.7%$17.77+2.0%-6.9%$12.07B$5.68B18.54160Positive News Related Companies and Tools Related Companies Taysha Gene Therapies Competitors Zillow Group Competitors W.P. Carey Competitors Houlihan Lokey Competitors Jefferies Financial Group Competitors Gaming and Leisure Properties Competitors Healthpeak Properties Competitors Regency Centers Competitors American Homes 4 Rent Competitors Host Hotels & Resorts Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:HHH) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Howard Hughes Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Howard Hughes With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
